IPD · ASX

Impedimed Limited (ASX:IPD)

AU$0.033

 0.0 (0.0%)
ASX:Live
09/05/2025 03:24:38 PM
Recent Earnings upgrade HALO Ords HALO Consensus Value GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IPD Overview

IPD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About IPD

Website

Impedimed Limited

Telephone

61.7.3860.3700

Address

Unit 1 50 Parker Court Pinkenba, Queensland (QLD) 4008

Description

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.

IPD Price Chart

Key Stats

Market Cap

AU$66.91M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.03 - 0.09

Trade Value (12mth)

AU$20,890.00

1 week

-15.38%

1 month

-5.71%

YTD

-37.74%

1 year

-57.69%

All time high

1.74

Key Fundamentals

EPS 3 yr Growth

-43.00%

EBITDA Margin

-210.50%

Operating Cashflow

-$18m

Free Cash Flow Return

-34.30%

ROIC

-38.20%

Interest Coverage

-233.60

Quick Ratio

6.20

Other Data

Shares on Issue (Fully Dilluted)

2023m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.51

IPD Announcements

Latest Announcements

Date Announcements

30 April 25

Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr

×

Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr

30 April 25

Investor Presentation

×

Investor Presentation

29 April 25

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

×

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

28 April 25

Change of Director's Interest Notice - Ms Janelle Delaney

×

Change of Director's Interest Notice - Ms Janelle Delaney

28 April 25

Change of Director's Interest Notice - Mr Andrew Grant

×

Change of Director's Interest Notice - Mr Andrew Grant

28 April 25

Change of Director's Interest Notice - Ms Fiona Bones

×

Change of Director's Interest Notice - Ms Fiona Bones

24 April 25

Application for quotation of securities - IPD

×

Application for quotation of securities - IPD

24 April 25

Application for quotation of securities - IPD

×

Application for quotation of securities - IPD

17 April 25

Notification of Quarterly Results & Investor Conference Call

×

Notification of Quarterly Results & Investor Conference Call

14 April 25

Change of registry address notification

×

Change of registry address notification

09 April 25

ImpediMed anticipates no material impact from U.S. tariffs

×

ImpediMed anticipates no material impact from U.S. tariffs

02 April 25

Notification of cessation of securities - IPD

×

Notification of cessation of securities - IPD

07 March 25

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

×

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

07 March 25

S&P DJI Announces March 2025 Quarterly Rebalance

×

S&P DJI Announces March 2025 Quarterly Rebalance

26 February 25

Appendix 4D and Interim Financial Report

×

Appendix 4D and Interim Financial Report

07 February 25

Notification regarding unquoted securities - IPD

×

Notification regarding unquoted securities - IPD

06 February 25

ImpediMed secures US$15 million growth capital facility

×

ImpediMed secures US$15 million growth capital facility

06 February 25

Proposed issue of securities - IPD

×

Proposed issue of securities - IPD

31 January 25

Quarterly Activities Report and Appendix 4C - Dec-2024 Qtr

×

Quarterly Activities Report and Appendix 4C - Dec-2024 Qtr

31 January 25

Investor Presentation

×

Investor Presentation

31 January 25

Application for quotation of securities - IPD

×

Application for quotation of securities - IPD

31 January 25

Application for quotation of securities - IPD

×

Application for quotation of securities - IPD

31 January 25

Change of Director's Interest Notice - Ms Fiona Bones

×

Change of Director's Interest Notice - Ms Fiona Bones

31 January 25

Change of Director's Interest Notice - Ms Janelle Delaney

×

Change of Director's Interest Notice - Ms Janelle Delaney

31 January 25

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

×

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

IPD Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.4 3.4 14.0 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.2 -10.3 -0.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -15.4 -5.7 -12.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.03 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 84.3 2.4 -46.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,679 1,800 2,022 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,679 1,800 2,022 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 11 11 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.7 7.4 -9.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 8 9 10 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -13 -14 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.4 -2.3 -2.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -126.3 -120.4 -135.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 226 220 235 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -18 -20 -22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.4 -10.4 -6.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -174.7 -179.6 -210.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 3 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -21 -23 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.8 -7.6 -4.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -200.9 -201.4 -232.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -21 -22 -21 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -20 -21 -20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.0 -3.3 3.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -188.1 -180.9 -191.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -16 -18 -18 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 6 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -5 -6 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 40 28 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -16 -18 -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.0 -17.3 3.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.5 -1.6 -1.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 41 46 25 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 59 69 47 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -41 -44 -23 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 8 8 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 51 61 41 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 51 62 42 Lock Lock Lock
     Growth % Lock Lock Lock Lock 98.8 21.5 -33.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.9 -29.9 -42.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.9 -33.7 -48.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -55.0 -40.2 -46.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -51.8 -36.3 -38.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -40.8 -31.9 -34.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -659.2 -599.4 -233.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.2 2.2 1.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -79.5 -72.7 -57.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.4 8.9 6.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.3 8.7 6.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 87.3 88.0 83.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -216.3 -308.7 -382.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.4 2.6 2.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 36.9 28.8 31.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.3 0.2 0.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 25.0 11.9 10.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -203.0 -194.6 -200.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -36.5 -32.1 -44.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.9 -29.9 -42.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.9 -33.7 -48.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -38.9 -33.7 -48.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 9.9 12.7 11.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 155.1 141.0 134.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 165.0 153.7 146.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 29.3 29.3 18.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 135.7 124.4 127.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.51%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IPD Shortsell

Frequently Asked Questions

The current share price of Impedimed Limited (IPD:ASX) is AU$0.033.
The 52-week high share price for Impedimed Limited (IPD:ASX) is AU$0.09.
The 52-week low share price for Impedimed Limited (IPD:ASX)? is AU$0.03.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) has a franking level of 0.0%.
Impedimed Limited (IPD:ASX) is classified in the Healthcare.
The current P/E ratio for Impedimed Limited (IPD:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.